Schedule 13D ownership disclosure

Arcturus Therapeutics Holdings Inc

Security class unavailable · CUSIP: 03969T109

Event date: 2021-08-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-21-244861
Form type
SC 13D/A
Filer
Arcturus Therapeutics Holdings Inc.
CIK
CIK 1768224
Filed
Aug 12, 2021
Reporting period
Aug 10, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub